This blood test measures IgG and IgM antibodies to cytomegalovirus, showing whether you have had a past infection or a more recent exposure. It suits anyone wanting to check their CMV immune status, including those planning pregnancy or with a weakened immune system.
2 biomarkers as listed by Medichecks.
Cytomegalovirus (CMV) is a common virus that many people encounter without noticing symptoms, though it can cause flu-like illness and matters more if your immune system is compromised or you are trying to conceive. This test measures two antibodies, IgG and IgM, which together indicate whether you have been exposed to CMV at some point (IgG) or more recently (IgM).
We do not hold a comparison group for this test, so we cannot say how its £89 price or two-marker scope stacks up against similar antibody panels from other providers. Collection needs a venous blood draw, either in a Medichecks clinic or through a home nurse visit, which is less convenient than a finger-prick kit and is reflected in a middling collection convenience score.
The clinical depth score is high because two targeted antibodies are exactly what is needed to answer the immunity question this test asks. Clarity and documentation score well because the listing sets out the biomarkers, turnaround and collection options clearly, though it does not describe what the report itself looks like. Results and follow-up reflects that every test includes a doctor's written comment on your results.
This test is a sensible choice if you want to understand your CMV immunity status, for example ahead of pregnancy or if you have a weakened immune system and want to know your baseline exposure history. It also suits anyone who has had CMV-like symptoms and wants antibody confirmation rather than a guess.
We do not have data on a directly comparable CMV antibody test from another provider, so we cannot point you to a cheaper or deeper alternative here. If you need a broader look at your immune status rather than just CMV, a wider immunity panel would tell you more.
Medichecks takes a venous blood sample, either at one of its clinics or via a home nurse visit; this test does not offer an at-home finger-prick option. The sample is sent to the lab for analysis of CMV IgG and IgM antibody levels, and Medichecks states results are typically ready within 5 days. Every result comes with a doctor's written comment as standard.
This focused two-marker test checks IgG and IgM antibodies to cytomegalovirus (CMV), showing past or more recent exposure. At £89 we hold no direct comparison for it, so we cannot say how it prices against alternatives, but every result comes with a doctor's written comment. The main trade-off is that it needs a clinic or nurse visit rather than a simple finger-prick.
The listing publishes a short description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
2 biomarkers, placing it in the 76th percentile of immunity tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 5 days, slower than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.5 from 2,477 reviews; accredited lab (UKAS ISO 15189 partner labs); doctor review as standard; trading 25+ years.
£89.00 against a median of £124.63 for the 88 similarly sized immunity tests we track (-29%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Highly rated for depth and priced well below the market
An 8-marker blood test covering white and red blood cells, vitamin D, B12, iron status and inflammation, for a broad check of immune-related health.
Six-marker immunity panel below the category median
A six-marker blood panel covering IgG, IgM and IgA antibodies plus total protein, albumin and globulin, for anyone investigating frequent infections or possible immune deficiency.
Combined Covid tests, discontinued from 30 Sept 2026
A combined blood test measuring both nucleocapsid antibodies, which indicate past infection, and spike protein antibodies, which indicate a vaccine or infection response.
Broad 13-marker urine panel, competitively priced
A urine analysis under the microscope plus a culture to check for bacteria, covering signs of infection, kidney health and metabolic changes. Suits monitoring urinary symptoms or investigating an abnormal result.
